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Abstract
Background: ADHD is a common and disabling disorder, with an increased risk for coexisting disorders, substance
abuse and delinquency. In the present study, we aimed at exploring ADHD and criminality. We estimated the
prevalence of ADHD among longer-term prison inmates, described symptoms and cognitive functioning, and
compared findings with ADHD among psychiatric outpatients and healthy controls.
Methods: At Norrtälje Prison, we approached 315 male inmates for screening of childhood ADHD by the Wender
Utah Rating Scale (WURS-25) and for present ADHD by the Adult ADHD Self-Report Screener (ASRS-Screener). The
response rate was 62%. Further, we assessed 34 inmates for ADHD and coexisting disorders. Finally, we compared
findings with 20 adult males with ADHD, assessed at a psychiatric outpatient clinic and 18 healthy controls.
Results: The estimated prevalence of adult ADHD among longer-term inmates was 40%. Only 2 out of 30 prison
inmates confirmed with ADHD had received a diagnosis of ADHD during childhood, despite most needed health
services and educational support. All subjects reported lifetime substance use disorder (SUD) where amphetamine
was the most common drug. Mood and anxiety disorders were present among half of subjects; autism spectrum
disorder (ASD) among one fourth and psychopathy among one tenth. Personality disorders were common; almost
all inmates presented conduct disorder (CD) before antisocial personality disorder (APD). Prison inmates reported
more ADHD symptoms during both childhood and adulthood, compared with ADHD psychiatric outpatients.
Further, analysis of executive functions after controlling for IQ showed both ADHD groups performed poorer than
controls on working memory tests. Besides, on a continuous performance test, the ADHD prison group displayed
poorer results compared with both other groups.
Conclusions: This study suggested ADHD to be present among 40% of adult male longer-term prison inmates.
Further, ADHD and coexisting disorders, such as SUD, ASD, personality disorders, mood- and anxiety disorders,
severely affected prison inmates with ADHD. Besides, inmates showed poorer executive functions also when
controlling for estimated IQ compared with ADHD among psychiatric outpatients and controls. Our findings imply
the need for considering these severities when designing treatment programmes for prison inmates with ADHD.
Background
ADHD is a common, inherited and disabling developmen-
tal disorder with early onset. Most often ADHD persists
across the life span, affecting 2-4% of adults [1]. The core
symptoms of ADHD are inattention, hyperactivity and
impulsivity. Further, deficits in executive functioning are
commonplace, such as planning, organising, exerting self-
control, working memory, and affect regulation. Therefore,
ADHD affects educational and occupational performances,
psychological functioning, and social skills. Adults with
ADHD are at increased risk for unemployment, sick leave,
coexisting disorders, abuse, and antisocial behaviour lead-
ing to conviction [2,3]. Nearly 80% of adults with ADHD
present with at least one coexisting psychiatric disorder
[3,4]. Further, studies display ADHD to be common
among prison inmates [5-9]. However, little attention has
been paid to profiles of ADHD symptoms and executive
functions of prison inmates compared with other groups
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pharmacological treatment for ADHD among prison
inmates remain unexplored. The clinical presentation has
shown to change with age, as hyperactivity declines,
whereas inattention and executive dysfunction persist,
thus representing the core features of adult ADHD
[11,12]. However, most previous studies have excluded
prison inmates, questioning how relevant these findings
a r et op r i s o ni n m a t e s .T og a i ns o m em o r ei n f o r m a t i o n ,w e
evaluated ADHD and criminality. The first aim of this
study was to estimate the prevalence of ADHD among
longer-term inmates of a high-security Swedish prison.
The second aim was to describe ADHD, coexisting disor-
ders, and executive functions among prison inmates. The
final aim was to compare these findings with ADHD psy-
chiatric outpatients and healthy controls.
We hypothesized that ADHD would be common
among this group comprising mainly longer-term prison
inmates, typically convicted of crimes because of vio-
lence and drugs. Also, we hypothesized that they would
present more severe ADHD symptoms across the life-
span, more common coexisting psychiatric disorders,
and poorer executive functions compared with the other
groups.
Methods
The present study included an estimation of the preva-
lence of ADHD among longer-term prison inmates.
Further, it included a description of ADHD and execu-
tive functions among prison inmates compared with
ADHD among psychiatric outpatients and healthy con-
trols. The Regional Ethical Board in Stockholm
approved the studies. Participants provided written
informed consents before study procedures.
Participants
Norrtälje Prison is a high-security prison placed outside
Stockholm, Sweden, serving the entire country, hosting
200 adult male inmates. The prison holds mainly
longer-term inmates, typically convicted of crimes
because of drugs or violence.
Figure 1 shows the study flowchart. Norrtälje Prison
hosted 589 inmates between December 2006 and April
2009. Of those inmates, we did not invite 200 for
screening, as we could not include them in the following
trial because of deportation out of the country after
served conviction. Further, we did not approach 74
inmates because of practical reasons, or if we considered
them as too mentally affected to take part. Thus, a spe-
cially trained correction officer successively approached
315 prison inmates for screening during the study per-
iod. Another purpose of screening was to identify sub-
jects for a diagnostic evaluation for ADHD before
recruitment for a clinical trial. Therefore, we ended
recruitment as we had randomised all 30 subjects for
the trial in April 2009.
Following the screening survey, we performed exten-
sive diagnostic assessments for ADHD and coexisting
disorders among a group of inmates. We selected sub-
jects first according to their origin, as the Stockholm
County Council funded the assessments as part of regu-
lar clinical practice. Thus, we invited all prison inmates
marking adult ADHD by the screening, registered in the
Stockholm County, with at least 14 months left to con-
ditional release, and approved by the security officers to
stay at the ADHD ward. By this pre-screening, we evalu-
ated if subjects with ADHD would fulfil criteria for
taking part in the following clinical trial with methyl-
phenidate (Ginsberg and Lindefors, unpublished data).
Subjects with coexisting disorders, such as ASD, anxiety
and depression could take part if considered stable by
the investigator at the assessment. Further, the general
cognitive functioning had to be above the level of men-
tal retardation. In addition, subjects could continue
stable pharmacological treatment for coexisting disor-
ders if we did not suspect treatment interfering with
methylphenidate. Additionally, subjects had to be free
from serious medical illnesses. Thus, after meeting cri-
teria for the following trial and providing a written
informed consent, the subject could take part in the
diagnostic evaluation.
We considered 47 prison inmates for assessment.
However, we excluded one subject because of an exclu-
sion criterion, whereas six subjects denied taking part.
Of 40 consented subjects, six dropped out during the
assessments. Therefore, we finally assessed 34 subjects
and could confirm ADHD among 30 of them (Figure 1).
When appropriate, we extended the evaluation to con-
firm ASD in consistence with DSM-IV. We defined
ASD as fulfilling the criteria for Autistic syndrome,
Asperger syndrome or Pervasive developmental disorder,
not otherwise specified (PDD-NOS). This evaluation
included the Asperger Syndrome Screening Question-
n a i r e( A S S Q )[ 1 3 ] ,t h eD i a g n o s t i cI n t e r v i e wf o rS o c i a l
and Communication Disorders (DISCO) [14,15], and
the Autism Diagnostic Observation Schedule (ADOS),
module 4 [16].
The psychiatric outpatient study group comprised 20
a d u l tm e nw i t hA D H D ,1 8o ft h e mw i t hA D H Do ft h e
combined type, and two with the predominantly inatten-
tive subtype. We consecutively recruited these subjects to
another study [17] between 2004 and 2006, from the Neu-
ropsychiatric Unit, Karolinska University Hospital; a psy-
chiatric outpatient tertiary unit specialised in ADHD.
Notably, the exclusion criteria for taking part were differ-
ent among psychiatric outpatients, as ongoing pharmaco-
logical treatment for coexisting disorders, APD, ASD, 70 >
IQ < 85, or pure ‘sluggish, inattentive’ ADHD [18,19]
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difference in IQ between groups. Thus, we controlled for
IQ in the statistical analyses of executive functions.
The control group [17] comprised 18 adult healthy
males not needing psychiatric care, assessment for learn-
ing difficulties or educational support during childhood.
Further, they did not need psychiatric care during the
present study. We recruited age-matched controls from
advertisement on fitness training centres in Stockholm
City and among friends of staff-members.
Procedures
Estimation of ADHD prevalence among longer-term prison
inmates
WURS is a 61-item self-administered scale for rating fre-
quencies of ADHD childhood symptoms and behaviours
retrospectively on a 5-point scale, from 0 = n o ta ta l lo r
slightly,t o4=very much.T h es u b s c a l eW U R S - 2 5p r o -
vides a total sum score (range 0-100) by summing those
25 items best discriminating between ADHD and con-
trols [20]. According to the originators, a cut-off score of
36 is 96% sensitive and specific for identifying childhood
ADHD among the general population [20].
The ASRS-Screener comprises the 6 out of 18 most
predictive items of the Adult ADHD Self-Report Scale
(ASRS) [21] for defining present ADHD in adulthood.
Fulfilling at least 4 out of 6 significant items [22] on
ASRS-Screener defines adult ADHD. Both scales are
standard tools in clinical practice, despite the lack of
Swedish validations. In this study, we defined adult
ADHD as reaching the cut-off levels for WURS-25 and
ASRS-Screener, respectively.
Assessment for ADHD among prison inmates
Board certified psychiatrists and clinical psychologists
well experienced in ADHD, conducted the clinical
assessments. We confirmed ADHD in accordance to
DSM-IV [23]. The evaluations included a semi-struc-
tured clinical diagnostic interview for ADHD based on
the DSM-IV-criteria [23]. Further, ASRS [24] is an
18-item self-administered scale with appropriate psycho-
metric properties [25] based on the DSM-IV criteria and
adjusted to reflect ADHD symptoms as seen in adults
[22]. We used a non-validated Swedish version of the
ASRS [24] for rating symptom frequencies on a 5-point
scale, from 0 = never;t o4=very often, providing a total
sum score (range 0-72).
Figure 1 Flow chart of the screening procedures and diagnostic assessments.
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from parents or other significant others by question-
naires, before psychologists or psychiatrists performed
interviews. The questionnaires included the Five to Fif-
teen (FTF) questionnaire [26,27] and the Conners’ Brief
Parent Rating Scale - Conners’ Hyperactivity Index
[28,29], respectively.
The Five to Fifteen (FTF) questionnaire [26,27] elicits
childhood symptoms and developmental problems of
ADHD and coexisting disorders in the ages five to fif-
teen years. The FTF shows acceptable to excellent inter-
rater and test-retest reliability and comprises 181 items
scored on a 3-point scale, from 0 = does not apply,t o
2=definitely applies.
The Conners’ Brief Parent Rating Scale - Conners’
Hyperactivity Index is validated in several countries.
This scale describes ADHD and oppositional defiant
symptoms and behaviours in children up to 10 years of
age [28], comprises 10 items, scored 0-3, and provides a
total sum score (0-30).
We collected additional collateral information by med-
ical records from child- and adolescent psychiatry,
school health services, adult psychiatry and forensic psy-
chiatry. Further, we evaluated coexisting disorders by
the Structured Clinical Interview for DSM-IV Axis I
Disorders (SCID I) [30], the Hare Psychopathy Check
List-Revised (PCL-R), a semi-structured interview defin-
ing psychopathy by a total sum-score ≥ 30 [31], and the
self-rated version of the Structured Clinical Interview
for DSM-IV Axis II personality disorders, the SCID II
Patient Questionnaire (SCID II PQ). We estimated fre-
quencies of personality disorders by increasing the
screening cut-off level for each personality disorder by
one score. This procedure has shown an acceptable
agreement with the SCID II interview [32]. Furthermore,
the evaluation comprised a medical history, physical
examination, routine laboratory tests, urine drug screen-
ing and a neuropsychological test battery assessing IQ
and executive functions. As prison inmates often present
learning disabilities such as reading difficulties [9], we
assessed neuropsychological tests not requiring reading,
writing or mathematic skills. We estimated IQ by the
Wechsler Adult Intelligence Scale-III subtests Vocabulary
and Block Design, a dyadic short form correlating 0.92
with WAIS-III FSIQ [33,34].
Neuropsychological tests of executive functions
Digit Span [33] measures verbal working memory (WM)
whereas Span Board [35] measures visuospatial WM.
Further, we measured sustained attention, impulse inhi-
bition and other executive functions by the computer-
ized The Conners’ Continuous Performance Test II
(CCPT) [36]. The CCPT measure Hit RT reflects basic
reaction time, whereas Hit RT SE, Variability, Hit RT
block change, Hit SE block change, Hit RT ISI change,
Hit SE ISI change and Perseverations reflect variability
dependent measures. Finally, Omission errors, Commis-
sion errors, Detectability (d’), and Response style (â)
reflect accuracy dependent measures.
Assessment for ADHD among psychiatric outpatients
The diagnostic evaluation comprising neuropsychologi-
cal tests was similar as among prison inmates. However,
we did not assess SCID I, SCID II PQ, or PCL-R among
ADHD psychiatric outpatients. Case files provided infor-
mation on psychiatric comorbidity. Besides, the
self-rated Beck Depression Inventory [37,38], the Beck
Anxiety Inventory [39], and the Current ADHD Symp-
tom Scale - Self-Report Form [40], evaluated present
psychiatric symptoms.
Healthy controls
We interviewed controls for confirming the absence of
learning difficulties or psychiatric problems during
childhood and the study, respectively. Further, we used
the same self-rating scales for present psychiatric symp-
toms as among the psychiatric outpatients. Finally, the
neuropsychological tests were similar as for the other
groups.
Statistical analysis
Descriptive statistics summarised demographic data and
clinical characteristics of subjects. We carried out infer-
ential statistics by analyses of variance (ANOVA), Stu-
dent’st - t e s to rM a n n - W h i t n e yU-test for continuous
measures, and chi-square test or Fisher’s exact test for
categorical measures. Further, for comparing between
groups on neuropsychological measures, we performed a
series of analysis of variance (ANOVA) with Bonferroni
corrected post hoc comparisons, whenever main ana-
lyses reached significance. In addition, we aimed to con-
trol for IQ differences. Thus, we reanalysed measures of
executive functions (DS, SB, and CCPT) by performing
a series of ANCOVA with the dyadic estimated IQ
entered as a covariate. By these analyses, we evaluated if
lower IQ among prison inmates could explain their
executive dysfunctions. We present statistics from both
ANOVAs and ANCOVAs, as most measures of execu-
tive functions did not co-vary with IQ. We set the
alpha-level at p = .05. Finally, we performed all statisti-
cal analyses by SPSS 17.0 and 18.0, respectively.
Results
ADHD prevalence
Figure 1 presents a flowchart of the study. As calculated
from this figure, the total response rate was 62% (194/
315). We defined adult ADHD as reaching the cut-off
levels for both childhood and adult ADHD. By this pro-
cedure, we increased the specificity of the screening sur-
vey. When applying our predefinition of adult ADHD,
the prevalence rate was 45%, as 88 out of 194 subjects
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were slightly older and served longer convictions com-
pared with non-responders (Table 1). However, when
we assessed 34 subjects marking ADHD by the screen-
ing, we confirmed ADHD among 30 of them. Thus, the
screening survey pointed out to be 88% (30/34) specific.
Therefore, we imply a more conservative 40% ADHD
prevalence (0.88 × 45) among longer-term prison
inmates.
Clinical characteristics of ADHD among adult male
prison inmates
This study included an extensive diagnostic evaluation
of ADHD and coexisting disorders among a group of
prison inmates (Figure 1). Table 2 shows the clinical
characteristics of those 30 subjects confirmed with
ADHD. As shown, almost all subjects confirmed ADHD
of the combined type. Further, all subjects presented
coexisting disorders. In fact, all 30 subjects presented a
lifetime history of SUD, with amphetamine as the most
preferred drug among almost two thirds. In general, the
subjects showed an early onset of abuse and antisocial
behaviour. In addition, lifetime mood and anxiety disor-
ders were obvious among a vast majority and treated
among almost half of subjects at the assessment.
Besides, almost one fourth confirmed ASD, much more
common than we expected. On the other hand, psycho-
pathy was present among only one tenth, which was less
than we expected. Further, personality disorders were
present among 96% (22/23) of subjects. Among person-
ality disorders, antisocial, borderline, paranoid, narcissis-
tic, or obsessive-compulsive personality disorder were
most obvious. Further, there was a striking finding of
this study; despite most subjects reported prior need of
health services and educational support at school, few
received a diagnosis of ADHD during childhood. In
summary, prison inmates showed severe symptoms and
severities from ADHD, SUD, ASD, personality disorders,
mood- and anxiety disorders.
Comparisons between ADHD prison inmates, ADHD
psychiatric outpatients, and healthy controls
As depicted in Table 2, all three groups were of similar
age. Notably, 83% of ADHD prison inmates fulfilled
nine-year of compulsory school or less, compared with
30% among ADHD psychiatric outpatients, and 6%
among healthy controls, thus reflecting a remarkably
lower educational level among prison inmates.
Standardised questionnaires
The ADHD-prison group rated more ADHD related
symptoms and behaviours during both childhood and
adulthood, compared with the ADHD-psychiatry group
(Table 3). By contrast, when parents retrospectively
rated childhood symptoms and behaviours, differences
between groups were negligible, which we did not
expect. Table 3 presents statistics and Figure 2 presents
mean values (+/- 2 SE), respectively.
Neuropsychological tests
The dyadic estimation of IQ displayed similar IQ for
controls and the ADHD-psychiatry group; (Controls,
n = 18, M = 112 (± 9.65), range 97 - 132); (ADHD-
psychiatry, n = 20, M = 108.25 (±11.48), range 89 -
132). On the other hand, IQ was substantially lower
among ADHD prison inmates; (M = 95.18 (± 9.99),
range 78 - 113). The ADHD-prison group (n = 22) had
missing data for eight subjects. We expected significant
differences between groups on estimated IQ (F =1 4 . 7 6 ,
p < .001, hp
2 = .341) because of different inclusion cri-
teria. In fact, only the ADHD-prison group included
subjects with IQ between 70 and 85. As a result, 10%
(3/30) of prison inmates presented estimated dyadic IQ
within this range, specifically between 78 and 85. There-
f o r e ,w ee x c l u d e dt h o s et h r e ei n m a t e sw i t hI Q<8 5f o r
making inclusion criteria homogenous. However, the
ADHD-prison group still showed lower estimated IQ
after performing this procedure, compared with both
other groups (F = 10.49, p < .001, hp
2 = .28).
Neuropsychological tests of executive functions
The ADHD-prison group showed poorer results on sev-
eral measures of executive functions compared with both
other groups, also when controlling for IQ (Table 4).
On measures of working memory, controls outper-
formed the ADHD-psychiatry group on both verbal
(DS) and visuo-spatial working memory (SB). On the
other hand, the ADHD-psychiatry group outperformed
the ADHD-prison group on the same measures. How-
ever, when controlling for IQ, the differences in working
memory between ADHD groups no longer remained,
but controls still outperformed both ADHD groups.
Thus, both working memory tests showed executive dys-
functions associated with ADHD, also when controlling
for IQ.
Table 1 Demographic and Clinical Characteristics of
Prison Survey Sample
Study sample (n = 315) Responders
(n = 194)
Non
responders
a
(n = 121)
p
Men, n (%) 194 (100) 121 (100)
Age, median
b (IQR), y 31.3 (14) 29.4 (12) .028
d
Conviction time, median
b (IQR)
c,
months
69 (66) 60 (54) .030
d
aNon-responders were defined as those approached but actively refused to
take part, those who consented but not returned questionnaires, and those
who returned unanswered questionnaires;
bMedians were used as measures
of central tendencies as age and conviction time were non-normally
distributed;
c IQR: Interquartile range;
dMann-Whitney U-test was employed
due to non-normal distributed data.
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(CCPT), controls and the ADHD-psychiatry group
showed similar results. However, at least one of the
other groups outperformed the ADHD-prison group on
all four accuracy dependent measures,a n di nt h r e eo u t
of seven variability dependent measures, respectively.
On the other hand, there were no significant differences
in reaction time between groups (Table 4 and Figure 3).
Notably, 5 out of 27 (18.5%) subjects among the
ADHD-prison group showed remarkably increased
values (T-score >200) on Perseverations, a measure con-
sidered to reflect flexibility. Therefore, we performed
analyses both including and excluding subjects with
extreme values. However, we observed similar results on
Perseverations also when excluding those subjects, thus
implying decreased flexibility among prison inmates
with ADHD. Further, estimated IQ did not explain the
CCPT results in this study (Table 4).
Table 2 Demographic and Clinical Characteristics of Assessed Groups; ADHD-prison group, ADHD-psychiatry
group, Healthy controls. Not applicable = N/A
ADHD-prison, n = 30 ADHD-psychiatry, n = 20 Controls,
n=1 8
Fo r
c
2
p
Age, mean, (SD), y 34.4 (10.67) 33.4 (8.65) 35.2 (9.85) .14 .87
e
Educational level, nine-year compulsory school or less, n (%) 25 (83) 6 (30) 1 (6) 39.28 < .001
e
ADHD, combined, n (%) 28 (93) 18 (90) N/A
ADHD, inattentive, n (%) 2 (7) 2 (10) N/A
≥1 current co-morbid disorder, n (%)
a 15 (50) 12 (60) N/A .569
Autism spectrum disorder
b 7 (23) N/A N/A
Mood and anxiety disorder, lifetime
a 22 (73) N/A N/A
Personality disorders, (N = 23)
c
Antisocial, n (%) 22 (96) N/A N/A
Borderline, n (%) 17 (74) N/A N/A
Paranoid, n (%) 17 (74) N/A N/A
Narcissistic, n (%) 15 (65) N/A N/A
Obsessive-Compulsive, n (%) 12 (52) N/A N/A
Passive-Aggressive, n (%) 11 (48) N/A N/A
Avoidant, n (%) 11 (48) N/A N/A
Depressive, n (%) 8 (35) N/A N/A
Dependent, n (%) 7 (30) N/A N/A
Schizotypal, n (%) 5 (22) N/A N/A
Schizoid, n (%) 2 (9) N/A N/A
Histrionic, n (%) 0 (0) N/A N/A
Substance use disorder, n (%)
a 30 (100) N/A N/A
Amphetamine preferred, n (%) 19 (63) N/A N/A
Cocaine preferred, n (%) 4 (13) N/A N/A
Alcohol preferred, n (%) 4 (13) N/A N/A
Psychopathy, n (%)
d 3 (10) N/A N/A
Concomitant psychotropic’s, n (%) 13 (43) N/A N/A
Onset of alcohol, mean (SD), y 11.9 (1.81) N/A N/A
Onset of illegal drugs, mean (SD), y 14.0 (2.41) N/A N/A
Onset of criminality, mean (SD), y 11.2 (3.40) N/A N/A
Educational assistance at school, n (%) 24 (80) N/A N/A
Child psychiatry/school health, n (%) 18 (60) N/A N/A
ADHD diagnosed in childhood, n (%) 2 (7) N/A N/A
aAccording to DSM-IV by the SCID I interview,
bAccording to DSM IV, Autism spectrum disorder includes both Asperger syndrome and PDD-NOS,
cFrequencies of
personality disorders were estimated by increasing the cut-off level for each personality disorder by one score, on the SCID II PQ to equal the cut-off score of the
SCID II interview,
dPsychopathy was defined as a total sum score of ≥30 by the PCL-R,
eAnalyses of variance (ANOVA) for continuous variables and Fisher’s exact
test for categorical variables.
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The present study included an estimation of ADHD pre-
valence among adult male longer-term prison inmates
from a high-security Swedish prison. Further, we evalu-
ated ADHD and executive functions among prison
inmates and then compared results with ADHD psychia-
tric outpatients and healthy controls. We estimated a
prevalence rate as high as 40% among these prison
inmates. Further, those inmates we later confirmed with
ADHD were severely affected and disabled from ADHD
Table 3 Self-rated ADHD symptoms and behaviours during both childhood and adulthood; parental ratings of
childhood ADHD-symptoms. All results divided by group
ADHD-psychiatry
n=2 0
ADHD-prison
n=3 0
tp
Self-rating questionnaires M (SD) M (SD)
WURS-25 54.70 (14.31) 67.43 (13.48) -3.19 .002
ASRS
a 45.11 (12.85) 55.30 (8.89) -3.28 .002
Parental rating/questionnaires completed by significant others
Five to Fifteen - Executive Functions Subscale
b 1.23 (0.59) 1.20 (0.44) 0.19 .848
Conners’ Hyperactivity Index
b 13.47 (10.34) 15.19 (8.07) -0.52 .608
a Data missing for one subject among the ADHD-psychiatry group;
b The FTF Executive Functions Subscale includes ADHD criteria according to DSM-IV. For 15/20
(75%) among the ADHD-psychiatry group and 16/30 (53%) among the ADHD-prison group, a significant other completed the FTF and the Conners’ Hyperactivity
Index. For all questionnaires, higher scores indicate increased problems.
Figure 2 Retrospective ratings of childhood symptoms by the Five to Fifteen questionnaire as completed by significant others, for the
ADHD-psychiatry group (n = 15) and the ADHD-prison group (n = 14), respectively.
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disorders, mood- and anxiety disorders. Previous studies
reported increased frequencies of major mental disor-
ders, personality disorders, and early adjustment pro-
blems among prison inmates, regardless of ADHD [41].
The present study confirms these observations. In addi-
tion, educational level and executive functions were
poorer among ADHD inmates compared with ADHD
psychiatric outpatients and controls. These findings
remained after controlling for IQ. Thus, our findings
imply prison inmates with ADHD to present a severely
affected group of ADHD.
Although ADHD is common among prison inmates,
prevalence rates are inconsistent, probably because of
different used criteria among different prison popula-
tions [5-9]. Further, symptoms of ADHD, such as hyper-
activity and impulsivity have shown to decline by age,
whereas inattention and executive dysfunction continue
[12]. Besides, most prevalence studies on male prison
inmates have been conducted among younger inmates
[8]. Further, knowledge is sparse on clinical features and
executive functions among adult male prison inmates
confirmed with ADHD [6-10] compared with adult
ADHD among other groups and controls.
To our best knowledge, this study is the first to report
a screening survey for ADHD, followed by extensive
evaluations of ADHD and coexisting disorders among
adult male longer-term prison inmates. The evaluations
incorporated both self-reports and confirming collateral
information from parents, medical records and school
reports. Additionally, evaluations included a physical
examination and neuropsychological assessments.
Further, we compared ADHD prison inmates with
ADHD psychiatric outpatients and controls for ADHD
symptom load, coexisting disorders and executive
functions.
Prevalence of ADHD among prison inmates
As hypothesized, ADHD was prevalent among these
adult male longer-term prison inmates with a median
age of 31 years. We estimated the prevalence as high as
40%, compared with previous findings by Rösler et al [8]
who reported a prevalence of 45%, though among
younger inmates (mean age 19). Thus, our results
Table 4 ANOVA statistics included post hoc IQ adjustments for tests of executive functions. The statistics F, p, and
hp2 presented for ANOVAs without IQ adjustments. On working memory tests, higher scores reflect better results,
whereas on Conners’ CPT II, higher scores reflect poorer results.
Test and measured function N F p hp
2 Post hoc test Post hoc adjusted for IQ
Measures of working memory Control:18
ADHD-psych: 20
ADHD-prison: 30
Digit Span 21.29 <.001 .396 C>Psych > Prison C > Psych = Prison
Span Board 24.88 <.001 .434 C>Psych > Prison C > Psych = Prison
Conners’ CPT II Control:18
ADHD-psych: 20
ADHD-prison: 27
CCPT reaction time
Hit RT .48 .617 .015 C = Psych = Prison C = Psych = Prison
CCPT variability
Variability 26.38 <.001 .460 C = Psych < Prison C = Psych < Prison
Hit RT block change .29 .749 .009 C = Psych = Prison C = Psych = Prison
Hit SE block change .165 .848 .005 C = Psych = Prison C = Psych = Prison
Hit RT ISI change 1.22 .302 .038 C = Psych = Prison C = Psych = Prison
Hit SE ISI change .662 .519 .021 C = Psych = Prison C = Psych = Prison
Perseverations 8.66 <.001 .218 C = Psych < Prison C = Psych < Prison
CCPT accuracy
Omission errors 16.23 <.001 .344 C = Psych < Prison C = Psych < Prison
Commission errors 12.61 <.001 .289 C = Psych < Prison C = Psych < Prison
Detectability (d’) 9.21 <.001 .229 C < Prison
Psych = C
Psych = Prison
C < Prison
Psych = C
Psych = Prison
Response style (beta) 4.27 .018 .121 Psych < Prison
Psych = C
Prison = C
Psych < Prison
Psych = C
Prison = C
Note: CCPT = Conners’ Continuous Performance Test; RT = reaction time; SE = standard error; ISI = interstimulus interval; N/A = not applicable
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Page 8 of 13suggest ADHD to be comparably present among older
and younger inmates. Our finding contradicts the com-
mon view of ADHD to decline by age. Thus, this symp-
tom reduction by age might not held true for ADHD
prison inmates. Further, the total survey response rate
was 62%, which we view as acceptable, considering a
common mistrust against authorities among prison
inmates. However, we have to consider the attrition rate
and its impact on the results. We imply that we not
exaggerated the ADHD prevalence, as we did not
approach inmates who we considered too psychiatric
affected to take part. In some of these cases, ADHD
might contribute to their psychiatric symptoms. On the
other hand, we can not exclude some selection bias at
the end of the study period when the study was more
commonly known in the Swedish prison and probation
service. It might be that some inmates recognised them-
selves as having ADHD and therefore applied for serving
conviction at Norrtälje Prison in hope for treatment.
However, as we screened the majority at the beginning
of the study period, we imply this potential bias to be of
minor importance. In summary, when considering the
specificity of the screening procedure, we suggest a 40%
ADHD prevalence rate among adult male longer-term
inmates from a high-security prison.
Clinical characteristics of ADHD
This study only partially supported our hypothesis that
ADHD prison inmates would present more severe ADHD
symptoms across the lifespan, compared with ADHD psy-
chiatric outpatients. The ADHD-prison group reported
more ADHD symptoms and behaviours during both child-
hood and adulthood. However, collateral information from
parents on childhood symptoms did not reveal any differ-
ences between groups. As a result, subjects rated more
childhood symptoms retrospectively compared with par-
ental ratings. This observation contradicts previous find-
ings by Barkley [42] who displayed adults with ADHD to
Figure 3 The Conners’ Continuous Performance Test II (CCPT). Results are presented for controls (n = 18), the ADHD-psychiatry group (n =
20), and the ADHD-prison group (n = 27), respectively. The CCPT results did not co-vary with IQ. Note: * the ADHD-prison group performed
significantly poorer than at least one of the other groups (ADHD-psychiatry and controls).
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Page 9 of 13underreport their symptoms compared with parents.
T h u s ,w h e nc o n s i d e r i n gt h en e g a t i v et r a j e c t o r yo ft h e s e
prison inmates and continuing ADHD symptoms, you
would predict symptoms to be obvious during childhood,
consistent with self-reports. Further, most subjects
reported previous need of health services and educational
support during childhood, pointing to obvious difficulties,
although not recognised as ADHD. Notably, prison
inmates showed a remarkably lower educational level
compared with both other groups. Lower IQ levels among
these inmates might partially explain these findings.
Further, executive dysfunctions may contribute to lower
school attendances and performances. In fact, we expect
educational underachievement among ADHD also with
normal IQ [43]. Besides, more hindering symptoms from
ADHD and coexisting learning disabilities, including dys-
lexia and externalising symptoms such as ODD and CD,
possibly contribute to poorer educational achievements
and early dropouts from school. Another explanation
might be prison inmates exaggerating their symptoms in
hope for methylphenidate treatment. However, parents of
both ADHD groups rated similarly on Conners’ Hyperac-
tivity Index. This index reflects externalising symptoms
besides ADHD, which is notable considering the negative
trajectory of our ADHD-prison group. Therefore, self-
reported childhood symptoms by prison inmates seem
more in line with their negative trajectories across time.
Further, symptoms of substance abuse, depression and
anxiety could mimic ADHD. However, our inmates were
kept from drugs for more than three months, in some
cases for years. Further, all coexisting disorders were stable
and treated at the assessment, thus implying present
symptoms to be ADHD related.
To summarise, our findings imply the importance of
recognising ADHD early and offering effective treatment
immediately. Prospective studies should evaluate if treat-
ment will reduce the risk for serious outcomes.
Coexisting disorders
As hypothesized, coexisting disorders were common
among our prison inmates. In fact, all subjects reported
a lifetime history of SUD, with amphetamine as the
most preferred drug of choice. Besides, abuse and anti-
social behaviour had an early onset, consistent with pre-
vious findings [44]. Additionally, anxiety disorders and
depression were common, and half of inmates received
treatment at the assessment. Further, all but one subject
displayed CD before APD. Notably, psychopathy was
present among only one tenth, which was fewer than we
expected, as all but one subject displayed APD. How-
ever, previous studies reported that most psychopaths
fulfil the criteria for APD, whereas the opposite is true
for only a minority of inmates. These findings signal
that psychopathy would be a more homogeneous
disorder than APD [31]. In addition, Soderstrom used a
3-factor model of PCL-R among forensic subjects for
distinguishing psychopathy traits and evaluating if cer-
tain traits reflected ADHD [45]. By this model, he
showed that total PCL-R scores, as well as Factor 2
(unemotionality) and Factor 3 (behavioural dyscontrol),
reflected ADHD. However, Factor 1 defining exagger-
ated self-opinion towards others and dishonesty did not
reflect ADHD. In fact, the literature considers these
interpersonal traits of Factor 1 to be most specific of
psychopathy. Besides, we confirmed ASD among almost
one fourth of ADHD prison inmates, mainly PDD-NOS.
We are not aware of any previous reports estimating the
prevalence of ASD among prison inmates. However,
Anckarsater [46] showed that ASD was more common
among forensic subjects than among the general popula-
tion. In that study [46], PDD-NOS presented the most
common ASD, paralleling our findings. In summary, we
suggest that ASD is common also among prison
inmates. However, studies comprising larger samples
need to confirm these preliminary findings. If ASD is
common among prison inmates, we need to consider
this for successfully meeting the specific needs of these
inmates.
Previous studies reported that personality disorders
are common among different ADHD populations, such
as prison inmates [9]. Recently, Rydén et al observed
that personality disorders were common among adults
with “pure” ADHD, ADHD combined with bipolar dis-
order, and bipolar disorder only, although most preva-
lent among “pure” ADHD (Rydén E, and collaborators,
personal communication). For defining personality dis-
orders, they used the same procedure as in the present
study. By comparing those, “pure” ADHD with our
ADHD prison inmates, most personality disorders
implied more common among inmates. However, his-
trionic, depressive, and schizoid personality disorder
implied more common among “pure” ADHD subjects
(Rydén E, and collaborators, personal communication).
Cognitive abilities
The present study supported our hypothesis that ADHD
prison inmates would present poorer cognitive abilities
compared with ADHD psychiatric outpatients and
healthy controls. As expected, the ADHD-prison group
showed lower estimated IQ. However, different inclusion
criteria could not explain the observed IQ differences
between groups, as differences remained when excluding
prison inmates with IQ < 85. As presented, both ADHD
groups displayed poorer executive functions compared
with controls, also when adjusting for IQ. Working
memory functions were similar between ADHD groups
when adjusting for IQ. Considering the CCPT results
overall, controls and the ADHD-psychiatry group
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Page 10 of 13showed similar results. Further, at least one of them
outperformed ADHD prison inmates on all accuracy
dependent measures,a n do ns e v e r a lvariability depen-
dent measures, respectively. On the other hand, reaction
time was comparable between groups, thus implying
slow reaction time not to be a concern among adult
A D H D .S u m m a r i s i n g ,t h e s ef i n d i n g sa r ei nl i n ew i t h
theories of ADHD as an executive disorder [47]. In
addition, these findings parallel recent reports by Wood
et al [48,49] who suggested that lower IQ does not
account for the key cognitive problems noted among
A D H D .F u r t h e r ,o n es t r i k i n gn o t i o no ft h ep r e s e n t
study, was the increased levels of Perseverations on the
CCPT, which reflects difficulties in holding back or
adjusting non-proper behaviours. Previous studies
reported response perseveration among ADHD subjects
s u f f e r i n gf r o mC D[ 5 0 - 5 2 ] ,a sw e l la sa m o n gp a t h o l o g i -
cal gamblers [53]. However, researchers interpreted
response perseveration among ADHD in different ways.
Quay [50,51] suggested increased thriving for rewards
among CD, because of a more actively working beha-
vioural activation (reward) system (BAS) compared with
the behavioural inhibition system (BIS). Reverse, he sug-
gested less active BIS compared with BAS among
ADHD. Beauchaine interpreted the opposite way [54],
as he suggested less active BAS among CD, resulting in
a reward-seeking behaviour as a stimulation seeking.
Finally, Seguin [55], Newman and Wallace [56,57]
respectively, suggested deficits in attending for periph-
eral information, which usually directs the subject chan-
ging for a more effective behaviour. Therefore, future
studies should explore the cognitive underpinnings of
response perseveration, as they remain elusive.
Limitations
We have to consider several limitations of this study. As
the attrition rate of the screening survey was 38%, we
must interpret the results with caution. However, we
imply that we not exaggerated the prevalence rate of
ADHD. Further, both rating scales used for screening
lack Swedish validations. Nevertheless, these scales are
used as standard tools in clinical practice. Besides, this
s t u d yi n c l u d e do n l ym a l el o n g e r - t e r mp r i s o ni n m a t e s ,
why results can not extend to female inmates or to
inmates serving shorter-term convicts. Further, there
might have been selection bias when recruiting for the
screening survey, mainly at the end of the study period
when the study was commonly known in the Swedish
Prison and Probation service. It might be that some
inmates recognised themselves as suffering from ADHD
and therefore applied for serving conviction at Norrtälje
Prison in hope for treatment. However, as we screened
t h em a j o r i t ya tt h eb e g i n n i n go ft h es t u d yp e r i o d ,w e
imply this potential bias as minor important. Further,
there might have been selection bias because of different
inclusion criteria between groups. Therefore, it implies a
selection of subjects among ADHD psychiatric outpati-
ents, functioning better than average, as treatment for
coexisting disorders excluded for the present study.
Actually, in clinical practice, adults with ADHD often
receive treatment for common coexisting disorders. On
the other hand, the ADHD-psychiatry group may better
reflect ADHD among the general population, as consid-
ered presenting less severe symptoms and severities
compared with psychiatric outpatients. Additionally,
there may have been a selection bias when recruiting
prison inmates for diagnostic assessments. We noticed a
few prison inmates denied taking part in the study in
lack of motivation for changing their behaviour, or resis-
tance to stay at the ADHD ward. The ward was apart
from other wards for reducing the risk of exposing
inmates to illicit drugs. As a result, study subjects
received less time for physical exercise and restricted
access to some prison programmes, as long as they
stayed at the ADHD ward. Therefore, a selection bias
towards more motivated prison inmates could have
been present. If so, the bias probably worked towards
better performances and higher functioning, than the
reverse. Finally, the study samples were small. However,
results were statistically significant despite small sample
sizes. Notably, the strength of this study was the exten-
sive clinical description of ADHD, coexisting disorders
and executive functioning among prison inmates, as well
as comparisons with ADHD psychiatric outpatients and
controls. The extensive diagnostic evaluation included
self-reported information, collection of collateral infor-
mation, physical examination, structured diagnostic
interviews and neuropsychological assessments. To our
best knowledge, such extensive evaluations of longer-
term prison inmates have not previously been reported.
We infer our reported findings of ADHD symptom
severity, coexisting disorders and executive functioning
among prison inmates, are clinical important and rele-
vant. We need to consider these severities when adjust-
ing existing, or designing new ADHD treatment
programmes for prison inmates. Further, these extensive
evaluations might provide helpful insight for addressing
future research on ADHD endophenotypes. Knowledge
on endophenotypes may promote individually tailored
treatments by identifying who will benefit from treat-
ment. Finally, we will report effects of methylphenidate
treatment among these ADHD prison inmates in
another paper (Ginsberg and Lindefors, unpublished
data).
Conclusions
This study suggested ADHD to be present among 40%
of adult male longer-term prison inmates. Diagnostic
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Page 11 of 13evaluations for ADHD among 30 inmates showed them
severely disabled from ADHD and coexisting disorders,
such as SUD, ASD, personality disorders, mood- and
anxiety disorders. Further, these ADHD prison inmates
displayed poorer executive functions, also when control-
ling for estimated IQ, compared with ADHD psychiatric
outpatients and healthy controls. We infer the reported
findings of ADHD symptom severity, coexisting disor-
ders and executive functioning among prison inmates,
are clinical important and relevant. These findings imply
the need for considering these severities when introdu-
cing ADHD treatment programmes for prison inmates.
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